Cancer Research Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

[Cancer Research 52, 1504-1509, March 15, 1992]
© 1992 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsuda, H.
Right arrow Articles by Hirohashi, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsuda, H.
Right arrow Articles by Hirohashi, S.

Different Pattern of Chromosomal Allele Loss in Multiple Hepatocellular Carcinomas as Evidence of Their Multifocal Origin1

Hitoshi Tsuda, Tatsuya Oda2, Michiie Sakamoto and Setsuo Hirohashi3

Pathology Division, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104, Japan

One of the most problematic aspects of surgery for hepatocellular carcinoma (HCC) is the frequent development of multiple tumors. Determination of the origin of multiple tumors, i.e., multifocal or metastatic, is important for predicting the clinical course of the disease after surgery. In order to clarify the origin of multiple tumors of HCC genetically, we examined patterns of loss of heterozygosity (LOH) on chromosome 16 for DNA isolated from 43 HCCs resected from 19 patients by analysis of restriction fragment length polymorphism. The cases were classified macro- and microscopically into 3 groups: multifocal origin; metastatic origin; and undetermined. Classification based on morphological features was shown to be well correlated with patterns of LOH in multiple tumors of HCC. Different patterns of LOH on chromosome 16 were detected in 8 of 11 patients with tumors of morphologically multifocal origin, whereas they were detected in none of 5 patients with tumors of morphologically metastatic origin. Among five patients with tumors of morphologically undetermined origin, a difference of LOH pattern among the tumors was detected in two, whereas in the other three, the pattern was identical between the tumors. A different pattern of LOH among HCCs arising in situ showed that they were composed of different clones, strongly suggesting their independent clonal origin and multifocal development. These results show that not only appropriate morphological observation but also examination of the LOH pattern on a particular chromosome is useful in diagnosis of multifocal HCC.

1 Supported in part by a Grant-in-Aid for the Comprehensive 10-Year Strategy for Cancer Control from the Ministry of Health and Welfare of Japan.

2 Awardee of a Research Resident Fellowship from the Foundation for Promotion of Cancer Research.

3 To whom requests for reprints should be addressed.

Received 10/14/91. Accepted 12/30/91.




This article has been cited by other articles:


Home page
Hum Mol GenetHome page
M. T. Engelmark, E. L. Ivansson, J. J. Magnusson, I. M. Gustavsson, A. H. Beskow, P. K.E. Magnusson, and U. B. Gyllensten
Identification of susceptibility loci for cervical carcinoma by genome scan of affected sib-pairs
Hum. Mol. Genet., November 15, 2006; 15(22): 3351 - 3360.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. K. Lee, K. Man, J. W. Ho, X. H. Wang, R. T.P. Poon, Y. Xu, K. T. Ng, A. C. Chu, C. K. Sun, I. O. Ng, et al.
FTY720: A Promising Agent for Treatment of Metastatic Hepatocellular Carcinoma
Clin. Cancer Res., December 1, 2005; 11(23): 8458 - 8466.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. B. Thomas and J. L. Abbruzzese
Opportunities for Targeted Therapies in Hepatocellular Carcinoma
J. Clin. Oncol., November 1, 2005; 23(31): 8093 - 8108.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
L Messerini, L Novelli, and C E Comin
Microvessel density and clinicopathological characteristics in hepatitis C virus and hepatitis B virus related hepatocellular carcinoma
J. Clin. Pathol., August 1, 2004; 57(8): 867 - 871.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
M. Sakon, K. Umeshita, H. Nagano, H. Eguchi, S. Kishimoto, A. Miyamoto, S. Ohshima, K. Dono, S. Nakamori, M. Gotoh, et al.
Clinical Significance of Hepatic Resection in Hepatocellular Carcinoma: Analysis by Disease-Free Survival Curves
Arch Surg, December 1, 2000; 135(12): 1456 - 1459.
[Abstract] [Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
M. Takata, N. Yamanaka, T. Tanaka, J. Yamanaka, S. Maeda, E. Okamoto, H. Yasojima, K. Uematsu, H. Watanabe, and Y. Uragari
What Patients Can Survive Disease Free After Complete Resection for Hepatocellular Carcinoma?: A Multivariate Analysis
Jpn. J. Clin. Oncol., February 1, 2000; 30(2): 75 - 81.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1992 by the American Association for Cancer Research.